UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer

Cancer Immunology, Immunotherapy, 2020-12, Vol.69 (12), p.2523-2532

2020

Volltextzugriff (PDF)

Effect of Wellness Education on Quality of Life of Patients With Non–Small Cell Lung Cancer Treated With First-Line Icotinib and on Their Family Caregivers

Integrative cancer therapies, 2019-04, Vol.18, p.1534735419842373-1534735419842373

2019

Volltextzugriff (PDF)

Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma

Cancer gene therapy, 2021-02, Vol.28 (1-2), p.89-97

2021

Volltextzugriff (PDF)

Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials

Clinical breast cancer, 2018-02, Vol.18 (1), p.63-70

2018

Volltextzugriff (PDF)

Real-world validation of the chemotherapy-induced nausea and vomiting predictive model and its optimization for identifying high-risk Chinese patients

Chinese medical journal, 2023-06, Vol.136 (11), p.1370-1372

2023

Volltextzugriff (PDF)

Prolonged administration of the granisetron transdermal delivery system reduces capecitabine plus oxaliplatin regimen induced nausea and vomiting

BMC cancer, 2024-07, Vol.24 (1), p.867-10, Article 867

2024

Volltextzugriff (PDF)

Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus

Journal of surgical oncology, 2018-03, Vol.117 (4), p.588-596

2018

Volltextzugriff (PDF)

Nomogram based on multiparametric analysis of early‐stage breast cancer: Prediction of high burden metastatic axillary lymph nodes

Thoracic cancer, 2023-12, Vol.14 (35), p.3465-3474

2023

Volltextzugriff (PDF)

Epifriedelinol Ameliorates DMBA-Induced Breast Cancer in Albino Rats by Regulating the PI3K/AKT Pathway

The Tohoku Journal of Experimental Medicine, 2022, Vol.257(4), pp.283-289

2022

Volltextzugriff (PDF)

Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study

BMC cancer, 2023-03, Vol.23 (1), p.198-198, Article 198

2023

Volltextzugriff (PDF)

Clinicopathological Features, Staging Classification, and Clinical Outcomes of Esophageal Melanoma: Evaluation of a Pooled Case Series

Frontiers in oncology, 2022-07, Vol.12, p.858145-858145

2022

Volltextzugriff (PDF)

Quercetin: A promising drug candidate against the potential SARS-CoV-2-Spike mutants with high viral infectivity

Computational and structural biotechnology journal, 2023-01, Vol.21, p.5092-5098

2023

Volltextzugriff (PDF)

Metabolic and Immunological Implications of MME + CAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational Opportunities

Biological procedures online, 2024-09, Vol.26 (1), p.29-21, Article 29

2024

Volltextzugriff (PDF)

Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial

Integrative cancer therapies, 2018-06, Vol.17 (2), p.444-450

2018

Volltextzugriff (PDF)

Baicalin reverses radioresistance in nasopharyngeal carcinoma by downregulating autophagy

Cancer cell international, 2020-01, Vol.20 (1), p.35-8, Article 35

2020

Volltextzugriff (PDF)

Traditional Chinese medicine formula 01 for nasopharyngeal carcinoma (NPC01) for head & neck cancer and health-related quality of life: a retrospective study

BMC complementary medicine and therapies, 2022-08, Vol.22 (1), p.216-216, Article 216

2022

Volltextzugriff (PDF)

Icotinib alone or with bevacizumab as first‐line therapy in Chinese patients with advanced nonsquamous non‐small cell lung cancer and activating EGFR mutations: A retrospective study

Thoracic cancer, 2021-09, Vol.12 (17), p.2369-2374

2021

Volltextzugriff (PDF)

Influence of wellness education on first-line icotinib hydrochloride patients with stage IV non–small cell lung cancer and their family caregivers

Current problems in cancer, 2018-05, Vol.42 (3), p.358-366

2018

Volltextzugriff (PDF)

Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial

Clinical cancer research, 2021-02, Vol.27 (4), p.1003-1011

2021

Volltextzugriff (PDF)

Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune

Biomedicine & pharmacotherapy, 2017-12, Vol.96, p.378-383

2017

Volltextzugriff (PDF)

Effect of traditional Chinese medicine on pyrotinib-associated diarrhea in patients with HER2-positive breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e24096-e24096

2022

Volltextzugriff (PDF)

Oxymatrine Inhibits Development of Morphine-Induced Tolerance Associated With Decreased Expression of P-glycoprotein in Rats

Integrative cancer therapies, 2010-06, Vol.9 (2), p.213-218

2010

Volltextzugriff (PDF)

Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma

Apoptosis (London), 2024-06, Vol.29 (5-6), p.681-692

2024

Volltextzugriff (PDF)

Effect of bevacizumab plus double dose icotinib on advanced non-small cell lung cancer with EGFR L858R mutation

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21020-e21020

2023

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(83)
Buchkapitel
(12)

Sprache

Englisch
(95)

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(59)
Oncology
(29)
Humans
(27)
Technology
(18)
Female
(15)
Apoptosis
(14)
Male
(14)
Patients
(14)
Chemotherapy
(13)
Cancer
(12)
Cancer Therapies
(12)
Computer Science
(12)
Computer Science, Artificial Intelligence
(12)
Computer Science, Theory & Methods
(12)
Metastasis
(12)
Animals
(10)
Medical Prognosis
(10)
Middle Aged
(9)
Breast Cancer
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer

Effect of Wellness Education on Quality of Life of Patients With Non–Small Cell Lung Cancer Treated With First-Line Icotinib and on Their Family Caregivers

Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma

Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials

Real-world validation of the chemotherapy-induced nausea and vomiting predictive model and its optimization for identifying high-risk Chinese patients

Prolonged administration of the granisetron transdermal delivery system reduces capecitabine plus oxaliplatin regimen induced nausea and vomiting

Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus

Nomogram based on multiparametric analysis of early‐stage breast cancer: Prediction of high burden metastatic axillary lymph nodes

Epifriedelinol Ameliorates DMBA-Induced Breast Cancer in Albino Rats by Regulating the PI3K/AKT Pathway

Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study

Clinicopathological Features, Staging Classification, and Clinical Outcomes of Esophageal Melanoma: Evaluation of a Pooled Case Series

Quercetin: A promising drug candidate against the potential SARS-CoV-2-Spike mutants with high viral infectivity

Metabolic and Immunological Implications of MME + CAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational Opportunities

Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial

Baicalin reverses radioresistance in nasopharyngeal carcinoma by downregulating autophagy

Traditional Chinese medicine formula 01 for nasopharyngeal carcinoma (NPC01) for head & neck cancer and health-related quality of life: a retrospective study

Icotinib alone or with bevacizumab as first‐line therapy in Chinese patients with advanced nonsquamous non‐small cell lung cancer and activating EGFR mutations: A retrospective study

Influence of wellness education on first-line icotinib hydrochloride patients with stage IV non–small cell lung cancer and their family caregivers

Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial

Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune

Effect of traditional Chinese medicine on pyrotinib-associated diarrhea in patients with HER2-positive breast cancer

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

Oxymatrine Inhibits Development of Morphine-Induced Tolerance Associated With Decreased Expression of P-glycoprotein in Rats

Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma

Effect of bevacizumab plus double dose icotinib on advanced non-small cell lung cancer with EGFR L858R mutation

Aktive Filter

Suchergebnisse filtern